The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Needle-Free Drug Delivery Systems Market Research Report 2025
Synopsis
The global Needle-Free Drug Delivery Systems market was valued at US$ 9692 million in 2023 and is anticipated to reach US$ 16720 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Needle-Free Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Drug Delivery Systems.
Report Scope
The Needle-Free Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Needle-Free Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix
Segment by Type
Jet-Based
Spring-Based
Laser-Based
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Needle-Free Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Needle-Free Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Needle-Free Drug Delivery Systems market was valued at US$ 9692 million in 2023 and is anticipated to reach US$ 16720 million by 2030, witnessing a CAGR of 8.0% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Needle-Free Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Needle-Free Drug Delivery Systems.
Report Scope
The Needle-Free Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Needle-Free Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Needle-Free Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Antares Pharma
Pharmajet
Optinose
Valeritas
Crossject
Injex Pharma
3M Pharmaceuticals
Becton Dickinson (BD)
MedImmune
Mystic Pharmaceuticals
Zogenix
Segment by Type
Jet-Based
Spring-Based
Laser-Based
Segment by Application
Hospital
Clinic
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Needle-Free Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Needle-Free Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Needle-Free Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Needle-Free Drug Delivery Systems
1.2 Needle-Free Drug Delivery Systems Segment by Type
1.2.1 Global Needle-Free Drug Delivery Systems Market Value Comparison by Type (2024-2030)
1.2.2 Jet-Based
1.2.3 Spring-Based
1.2.4 Laser-Based
1.3 Needle-Free Drug Delivery Systems Segment by Application
1.3.1 Global Needle-Free Drug Delivery Systems Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Needle-Free Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Needle-Free Drug Delivery Systems Revenue 2019-2030
1.4.2 Global Needle-Free Drug Delivery Systems Sales 2019-2030
1.4.3 Global Needle-Free Drug Delivery Systems Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Needle-Free Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
2.2 Global Needle-Free Drug Delivery Systems Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Needle-Free Drug Delivery Systems Average Price by Manufacturers (2019-2024)
2.4 Global Needle-Free Drug Delivery Systems Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Needle-Free Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Needle-Free Drug Delivery Systems, Product Type & Application
2.7 Needle-Free Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Needle-Free Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Needle-Free Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Needle-Free Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Needle-Free Drug Delivery Systems Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Needle-Free Drug Delivery Systems Global Needle-Free Drug Delivery Systems Sales by Region: 2019-2030
3.2.1 Global Needle-Free Drug Delivery Systems Sales by Region: 2019-2024
3.2.2 Global Needle-Free Drug Delivery Systems Sales by Region: 2025-2030
3.3 Global Needle-Free Drug Delivery Systems Global Needle-Free Drug Delivery Systems Revenue by Region: 2019-2030
3.3.1 Global Needle-Free Drug Delivery Systems Revenue by Region: 2019-2024
3.3.2 Global Needle-Free Drug Delivery Systems Revenue by Region: 2025-2030
3.4 North America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Needle-Free Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Needle-Free Drug Delivery Systems Sales by Country (2019-2030)
3.4.3 North America Needle-Free Drug Delivery Systems Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Needle-Free Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Needle-Free Drug Delivery Systems Sales by Country (2019-2030)
3.5.3 Europe Needle-Free Drug Delivery Systems Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Needle-Free Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Needle-Free Drug Delivery Systems Sales by Country (2019-2030)
3.6.3 Asia Pacific Needle-Free Drug Delivery Systems Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Needle-Free Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Needle-Free Drug Delivery Systems Sales by Country (2019-2030)
3.7.3 Latin America Needle-Free Drug Delivery Systems Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Needle-Free Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Needle-Free Drug Delivery Systems Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Needle-Free Drug Delivery Systems Sales by Country (2019-2030)
3.8.3 Middle East and Africa Needle-Free Drug Delivery Systems Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Needle-Free Drug Delivery Systems Sales by Type (2019-2030)
4.1.1 Global Needle-Free Drug Delivery Systems Sales by Type (2019-2024)
4.1.2 Global Needle-Free Drug Delivery Systems Sales by Type (2025-2030)
4.1.3 Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2019-2030)
4.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2019-2030)
4.2.1 Global Needle-Free Drug Delivery Systems Revenue by Type (2019-2024)
4.2.2 Global Needle-Free Drug Delivery Systems Revenue by Type (2025-2030)
4.2.3 Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2019-2030)
4.3 Global Needle-Free Drug Delivery Systems Price by Type (2019-2030)
5 Segment by Application
5.1 Global Needle-Free Drug Delivery Systems Sales by Application (2019-2030)
5.1.1 Global Needle-Free Drug Delivery Systems Sales by Application (2019-2024)
5.1.2 Global Needle-Free Drug Delivery Systems Sales by Application (2025-2030)
5.1.3 Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2019-2030)
5.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2019-2030)
5.2.1 Global Needle-Free Drug Delivery Systems Revenue by Application (2019-2024)
5.2.2 Global Needle-Free Drug Delivery Systems Revenue by Application (2025-2030)
5.2.3 Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2019-2030)
5.3 Global Needle-Free Drug Delivery Systems Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Antares Pharma
6.1.1 Antares Pharma Corporation Information
6.1.2 Antares Pharma Description and Business Overview
6.1.3 Antares Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Antares Pharma Needle-Free Drug Delivery Systems Product Portfolio
6.1.5 Antares Pharma Recent Developments/Updates
6.2 Pharmajet
6.2.1 Pharmajet Corporation Information
6.2.2 Pharmajet Description and Business Overview
6.2.3 Pharmajet Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pharmajet Needle-Free Drug Delivery Systems Product Portfolio
6.2.5 Pharmajet Recent Developments/Updates
6.3 Optinose
6.3.1 Optinose Corporation Information
6.3.2 Optinose Description and Business Overview
6.3.3 Optinose Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Optinose Needle-Free Drug Delivery Systems Product Portfolio
6.3.5 Optinose Recent Developments/Updates
6.4 Valeritas
6.4.1 Valeritas Corporation Information
6.4.2 Valeritas Description and Business Overview
6.4.3 Valeritas Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Valeritas Needle-Free Drug Delivery Systems Product Portfolio
6.4.5 Valeritas Recent Developments/Updates
6.5 Crossject
6.5.1 Crossject Corporation Information
6.5.2 Crossject Description and Business Overview
6.5.3 Crossject Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Crossject Needle-Free Drug Delivery Systems Product Portfolio
6.5.5 Crossject Recent Developments/Updates
6.6 Injex Pharma
6.6.1 Injex Pharma Corporation Information
6.6.2 Injex Pharma Description and Business Overview
6.6.3 Injex Pharma Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Injex Pharma Needle-Free Drug Delivery Systems Product Portfolio
6.6.5 Injex Pharma Recent Developments/Updates
6.7 3M Pharmaceuticals
6.6.1 3M Pharmaceuticals Corporation Information
6.6.2 3M Pharmaceuticals Description and Business Overview
6.6.3 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.4.4 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio
6.7.5 3M Pharmaceuticals Recent Developments/Updates
6.8 Becton Dickinson (BD)
6.8.1 Becton Dickinson (BD) Corporation Information
6.8.2 Becton Dickinson (BD) Description and Business Overview
6.8.3 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product Portfolio
6.8.5 Becton Dickinson (BD) Recent Developments/Updates
6.9 MedImmune
6.9.1 MedImmune Corporation Information
6.9.2 MedImmune Description and Business Overview
6.9.3 MedImmune Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.9.4 MedImmune Needle-Free Drug Delivery Systems Product Portfolio
6.9.5 MedImmune Recent Developments/Updates
6.10 Mystic Pharmaceuticals
6.10.1 Mystic Pharmaceuticals Corporation Information
6.10.2 Mystic Pharmaceuticals Description and Business Overview
6.10.3 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product Portfolio
6.10.5 Mystic Pharmaceuticals Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Corporation Information
6.11.2 Zogenix Needle-Free Drug Delivery Systems Description and Business Overview
6.11.3 Zogenix Needle-Free Drug Delivery Systems Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Zogenix Needle-Free Drug Delivery Systems Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Needle-Free Drug Delivery Systems Industry Chain Analysis
7.2 Needle-Free Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Needle-Free Drug Delivery Systems Production Mode & Process
7.4 Needle-Free Drug Delivery Systems Sales and Marketing
7.4.1 Needle-Free Drug Delivery Systems Sales Channels
7.4.2 Needle-Free Drug Delivery Systems Distributors
7.5 Needle-Free Drug Delivery Systems Customers
8 Needle-Free Drug Delivery Systems Market Dynamics
8.1 Needle-Free Drug Delivery Systems Industry Trends
8.2 Needle-Free Drug Delivery Systems Market Drivers
8.3 Needle-Free Drug Delivery Systems Market Challenges
8.4 Needle-Free Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Needle-Free Drug Delivery Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Needle-Free Drug Delivery Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Needle-Free Drug Delivery Systems Market Competitive Situation by Manufacturers in 2023
Table 4. Global Needle-Free Drug Delivery Systems Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Needle-Free Drug Delivery Systems Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Needle-Free Drug Delivery Systems Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Needle-Free Drug Delivery Systems, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Needle-Free Drug Delivery Systems, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Needle-Free Drug Delivery Systems, Product Type & Application
Table 12. Global Key Manufacturers of Needle-Free Drug Delivery Systems, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Needle-Free Drug Delivery Systems by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Needle-Free Drug Delivery Systems as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Needle-Free Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Needle-Free Drug Delivery Systems Sales by Region (2019-2024) & (K Units)
Table 18. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2019-2024)
Table 19. Global Needle-Free Drug Delivery Systems Sales by Region (2025-2030) & (K Units)
Table 20. Global Needle-Free Drug Delivery Systems Sales Market Share by Region (2025-2030)
Table 21. Global Needle-Free Drug Delivery Systems Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2019-2024)
Table 23. Global Needle-Free Drug Delivery Systems Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Needle-Free Drug Delivery Systems Revenue Market Share by Region (2025-2030)
Table 25. North America Needle-Free Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Needle-Free Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 27. North America Needle-Free Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 28. North America Needle-Free Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Needle-Free Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Needle-Free Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Needle-Free Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 32. Europe Needle-Free Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 33. Europe Needle-Free Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Needle-Free Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Needle-Free Drug Delivery Systems Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Needle-Free Drug Delivery Systems Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Needle-Free Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Needle-Free Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Needle-Free Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Needle-Free Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Needle-Free Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Needle-Free Drug Delivery Systems Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Needle-Free Drug Delivery Systems Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Needle-Free Drug Delivery Systems Sales (K Units) by Type (2019-2024)
Table 51. Global Needle-Free Drug Delivery Systems Sales (K Units) by Type (2025-2030)
Table 52. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2019-2024)
Table 53. Global Needle-Free Drug Delivery Systems Sales Market Share by Type (2025-2030)
Table 54. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2019-2024)
Table 57. Global Needle-Free Drug Delivery Systems Revenue Market Share by Type (2025-2030)
Table 58. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2019-2024)
Table 59. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2025-2030)
Table 60. Global Needle-Free Drug Delivery Systems Sales (K Units) by Application (2019-2024)
Table 61. Global Needle-Free Drug Delivery Systems Sales (K Units) by Application (2025-2030)
Table 62. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2019-2024)
Table 63. Global Needle-Free Drug Delivery Systems Sales Market Share by Application (2025-2030)
Table 64. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Needle-Free Drug Delivery Systems Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2019-2024)
Table 67. Global Needle-Free Drug Delivery Systems Revenue Market Share by Application (2025-2030)
Table 68. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2019-2024)
Table 69. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2025-2030)
Table 70. Antares Pharma Corporation Information
Table 71. Antares Pharma Description and Business Overview
Table 72. Antares Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Antares Pharma Needle-Free Drug Delivery Systems Product
Table 74. Antares Pharma Recent Developments/Updates
Table 75. Pharmajet Corporation Information
Table 76. Pharmajet Description and Business Overview
Table 77. Pharmajet Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Pharmajet Needle-Free Drug Delivery Systems Product
Table 79. Pharmajet Recent Developments/Updates
Table 80. Optinose Corporation Information
Table 81. Optinose Description and Business Overview
Table 82. Optinose Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Optinose Needle-Free Drug Delivery Systems Product
Table 84. Optinose Recent Developments/Updates
Table 85. Valeritas Corporation Information
Table 86. Valeritas Description and Business Overview
Table 87. Valeritas Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Valeritas Needle-Free Drug Delivery Systems Product
Table 89. Valeritas Recent Developments/Updates
Table 90. Crossject Corporation Information
Table 91. Crossject Description and Business Overview
Table 92. Crossject Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Crossject Needle-Free Drug Delivery Systems Product
Table 94. Crossject Recent Developments/Updates
Table 95. Injex Pharma Corporation Information
Table 96. Injex Pharma Description and Business Overview
Table 97. Injex Pharma Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Injex Pharma Needle-Free Drug Delivery Systems Product
Table 99. Injex Pharma Recent Developments/Updates
Table 100. 3M Pharmaceuticals Corporation Information
Table 101. 3M Pharmaceuticals Description and Business Overview
Table 102. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. 3M Pharmaceuticals Needle-Free Drug Delivery Systems Product
Table 104. 3M Pharmaceuticals Recent Developments/Updates
Table 105. Becton Dickinson (BD) Corporation Information
Table 106. Becton Dickinson (BD) Description and Business Overview
Table 107. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Becton Dickinson (BD) Needle-Free Drug Delivery Systems Product
Table 109. Becton Dickinson (BD) Recent Developments/Updates
Table 110. MedImmune Corporation Information
Table 111. MedImmune Description and Business Overview
Table 112. MedImmune Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. MedImmune Needle-Free Drug Delivery Systems Product
Table 114. MedImmune Recent Developments/Updates
Table 115. Mystic Pharmaceuticals Corporation Information
Table 116. Mystic Pharmaceuticals Description and Business Overview
Table 117. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Mystic Pharmaceuticals Needle-Free Drug Delivery Systems Product
Table 119. Mystic Pharmaceuticals Recent Developments/Updates
Table 120. Zogenix Corporation Information
Table 121. Zogenix Description and Business Overview
Table 122. Zogenix Needle-Free Drug Delivery Systems Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Zogenix Needle-Free Drug Delivery Systems Product
Table 124. Zogenix Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Needle-Free Drug Delivery Systems Distributors List
Table 128. Needle-Free Drug Delivery Systems Customers List
Table 129. Needle-Free Drug Delivery Systems Market Trends
Table 130. Needle-Free Drug Delivery Systems Market Drivers
Table 131. Needle-Free Drug Delivery Systems Market Challenges
Table 132. Needle-Free Drug Delivery Systems Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Needle-Free Drug Delivery Systems
Figure 2. Global Needle-Free Drug Delivery Systems Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Needle-Free Drug Delivery Systems Market Share by Type in 2023 & 2030
Figure 4. Jet-Based Product Picture
Figure 5. Spring-Based Product Picture
Figure 6. Laser-Based Product Picture
Figure 7. Global Needle-Free Drug Delivery Systems Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Needle-Free Drug Delivery Systems Market Share by Application in 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Global Needle-Free Drug Delivery Systems Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Needle-Free Drug Delivery Systems Market Size (2019-2030) & (US$ Million)
Figure 14. Global Needle-Free Drug Delivery Systems Sales (2019-2030) & (K Units)
Figure 15. Global Needle-Free Drug Delivery Systems Average Price (USD/Unit) & (2019-2030)
Figure 16. Needle-Free Drug Delivery Systems Report Years Considered
Figure 17. Needle-Free Drug Delivery Systems Sales Share by Manufacturers in 2023
Figure 18. Global Needle-Free Drug Delivery Systems Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Needle-Free Drug Delivery Systems Players: Market Share by Revenue in 2023
Figure 20. Needle-Free Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Needle-Free Drug Delivery Systems Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Needle-Free Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 23. North America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 24. U.S. Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Needle-Free Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 27. Europe Needle-Free Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 28. Germany Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Needle-Free Drug Delivery Systems Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Needle-Free Drug Delivery Systems Revenue Market Share by Region (2019-2030)
Figure 35. China Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Taiwan Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Philippines Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America Needle-Free Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 46. Latin America Needle-Free Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 47. Mexico Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Needle-Free Drug Delivery Systems Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Needle-Free Drug Delivery Systems Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Needle-Free Drug Delivery Systems Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Needle-Free Drug Delivery Systems by Type (2019-2030)
Figure 56. Global Revenue Market Share of Needle-Free Drug Delivery Systems by Type (2019-2030)
Figure 57. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Needle-Free Drug Delivery Systems by Application (2019-2030)
Figure 59. Global Revenue Market Share of Needle-Free Drug Delivery Systems by Application (2019-2030)
Figure 60. Global Needle-Free Drug Delivery Systems Price (USD/Unit) by Application (2019-2030)
Figure 61. Needle-Free Drug Delivery Systems Value Chain
Figure 62. Needle-Free Drug Delivery Systems Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
